These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 32599334)

  • 1. Management of atrial fibrillation after transcatheter aortic valve replacement: Challenges and therapeutic considerations.
    Ammar A; Elbatran AI; Wijesuriya N; Saberwal B; Ahsan SY
    Trends Cardiovasc Med; 2021 Aug; 31(6):361-367. PubMed ID: 32599334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry.
    Vora AN; Dai D; Matsuoka R; Harrison JK; Hughes GC; Sherwood MW; Piccini JP; Bhardwaj B; Lopes RD; Cohen D; Holmes DR; Thourani VH; Peterson E; Kirtane A; Kapadia S; Vemulapalli S
    JACC Cardiovasc Interv; 2018 Sep; 11(17):1746-1756. PubMed ID: 30190063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the SOURCE XT Prospective Multicenter Registry.
    Tarantini G; Mojoli M; Windecker S; Wendler O; Lefèvre T; Saia F; Walther T; Rubino P; Bartorelli AL; Napodano M; D'Onofrio A; Gerosa G; Iliceto S; Vahanian A
    JACC Cardiovasc Interv; 2016 May; 9(9):937-46. PubMed ID: 27085579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR).
    Herold J; Herold-Vlanti V; Sherif M; Luani B; Breyer C; Bonaventura K; Braun-Dullaeus R
    BMC Cardiovasc Disord; 2017 Dec; 17(1):298. PubMed ID: 29262768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation.
    Kosmidou I; Liu Y; Alu MC; Liu M; Madhavan M; Chakravarty T; Makkar R; Thourani VH; Biviano A; Kodali S; Leon MB
    JACC Cardiovasc Interv; 2019 Aug; 12(16):1580-1589. PubMed ID: 31439338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve Replacement Among Patients With Atrial Fibrillation.
    Kapadia SR; Krishnaswamy A; Whisenant B; Potluri S; Iyer V; Aragon J; Gideon P; Strote J; Leonardi R; Agarwal H; Larrain G; Sanchez C; Panaich SS; Harvey J; Vahl T; Menon V; Wolski K; Wang Q; Leon MB
    Circulation; 2024 Mar; 149(10):734-743. PubMed ID: 37874908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on atrial fibrillation.
    Khaji A; Kowey PR
    Trends Cardiovasc Med; 2017 Jan; 27(1):14-25. PubMed ID: 27520496
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Pre-Existing and New-Onset Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve Replacement.
    Mentias A; Saad M; Girotra S; Desai M; Elbadawi A; Briasoulis A; Alvarez P; Alqasrawi M; Giudici M; Panaich S; Horwitz PA; Jneid H; Kapadia S; Vaughan Sarrazin M
    JACC Cardiovasc Interv; 2019 Nov; 12(21):2119-2129. PubMed ID: 31629743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apixaban in Patients With Atrial Fibrillation After Transfemoral Aortic Valve Replacement.
    Seeger J; Gonska B; Rodewald C; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2017 Jan; 10(1):66-74. PubMed ID: 27916486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal changes of new-onset atrial fibrillation in patients randomized to surgical or transcatheter aortic valve replacement.
    Jørgensen TH; Thyregod HG; Tarp JB; Svendsen JH; Søndergaard L
    Int J Cardiol; 2017 May; 234():16-21. PubMed ID: 28258844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Atrial Fibrillation and Atrial Flutter by Pacemaker Device Interrogation After Transcatheter Aortic Valve Replacement (TAVR): Implications for Management.
    Megaly M; Garcia S; Anzia LE; Morley P; Garberich R; Gornick CC; Lesser J; Sorajja P; Gössl M; Sengupta J
    J Invasive Cardiol; 2019 Jul; 31(7):E177-E183. PubMed ID: 31257211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiological consequences of the EAST-AFNET4 trial: AF is not an innocent bystander.
    Goette A
    Cardiovasc Res; 2020 Dec; 116(14):e200-e201. PubMed ID: 33205206
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticoagulation With or Without Antiplatelet Therapy Following Transcatheter Aortic Valve Replacement for Patients With Atrial Fibrillation: A Meta-Analysis.
    Yokoyama Y; Briasoulis A; Takagi H; Kuno T
    Cardiovasc Revasc Med; 2021 Mar; 24():42-47. PubMed ID: 32830088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting Atrial Fibrillation in the Transcatheter Aortic Valve Replacement Era.
    Parikh K; Dizon J; Biviano A
    Interv Cardiol Clin; 2018 Oct; 7(4):459-469. PubMed ID: 30274612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges in Aortic Stenosis: Review of Antiplatelet/Anticoagulant Therapy Management with Transcatheter Aortic Valve Replacement (TAVR): TAVR with Recent PCI, TAVR in the Patient with Atrial Fibrillation, and TAVR Thrombosis Management.
    Sherwood MW; Vora AN
    Curr Cardiol Rep; 2018 Oct; 20(12):130. PubMed ID: 30311013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of atrial fibrillation on outcomes in patients who underwent transcatheter aortic valve replacement.
    Maan A; Heist EK; Passeri J; Inglessis I; Baker J; Ptaszek L; Vlahakes G; Ruskin JN; Palacios I; Sundt T; Mansour M
    Am J Cardiol; 2015 Jan; 115(2):220-6. PubMed ID: 25465936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New-Onset Atrial Fibrillation After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis.
    Ryan T; Grindal A; Jinah R; Um KJ; Vadakken ME; Pandey A; Jaffer IH; Healey JS; Belley-Coté ÉP; McIntyre WF
    JACC Cardiovasc Interv; 2022 Mar; 15(6):603-613. PubMed ID: 35331452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation in patients undergoing transcatheter aortic valve implantation: epidemiology, timing, predictors, and outcome.
    Tarantini G; Mojoli M; Urena M; Vahanian A
    Eur Heart J; 2017 May; 38(17):1285-1293. PubMed ID: 27744287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New concepts in the therapy of atrial fibrillation.
    Cocco G; Jerie P
    Cardiol J; 2016; 23(1):3-11. PubMed ID: 26412599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.